Effect of eight-week online cognitive training in Parkinson's disease: A double-blind, randomized, controlled trial

被引:13
|
作者
van Balkom, Tim D. [1 ,2 ]
Berendse, Henk W. [3 ]
van der Werf, Ysbrand D. [2 ]
Twisk, Jos W. R. [4 ]
Peeters, Carel F. W. [5 ]
Hoogendoorn, Adriaan W. [6 ]
Hagen, Rob H. [7 ]
Berk, Tanja [7 ]
van den Heuvel, Odile A. [1 ,2 ]
Vriend, Chris [1 ,2 ]
机构
[1] Vrije Univ Amsterdam, Amsterdam Neurosci, Psychiat, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, Amsterdam Neurosci, Anat & Neurosci, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Amsterdam Neurosci, Neurol, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, Amsterdam Publ Hlth, Epidemiol & Biostat, Amsterdam UMC, POB 7057, Amsterdam, Netherlands
[5] Wageningen Univ & Res, Math & Stat Methods Grp Biometris, POB 16, NL-6700 AA Wageningen, Netherlands
[6] GGZ InGeest, Res & Innovat, Oldenaller 1, NL-1081 HL Amsterdam, Netherlands
[7] Dutch Parkinsons Dis Assoc, POB 46, NL-3980 CA Bunnik, Netherlands
关键词
Parkinson's disease; Cognitive training; RCT; Cognitive impairment; Dementia; Cognitive rehabilitation; DIAGNOSTIC-CRITERIA; IMPAIRMENT; DISORDER; DECLINE; BRAIN;
D O I
10.1016/j.parkreldis.2022.02.018
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: Cognitive training (CT) has been proposed as a treatment option for cognitive impairment in Parkinson's disease (PD). We aimed to assess the efficacy of adaptive, computerized CT on cognitive function in PD. Methods: In this double-blind, randomized controlled trial we enrolled PD patients that experienced substantial subjective cognitive complaints. Over a period of eight weeks, participants underwent 24 sessions of computerized multi-domain CT or an active control intervention for 45 min each (randomized 1:1). The primary outcome was the accuracy on the Tower of London task; secondary outcomes included effects on other neuropsychological outcomes and subjective cognitive complaints. Outcomes were assessed before and after training and at six-months follow-up, and analyzed with multivariate mixed-model analyses. Results: The intention-to-treat population consisted of 136 participants (n = 68 vs. n = 68, age M: 62.9y, female: 39.7%). Multivariate mixed-model analyses showed no group difference on the Tower of London accuracy corrected for baseline performance (n = 130): B: 0.06, 95% CI: 0.27 to 0.15, p = 0.562. Participants in the CT group were on average 0.30 SD (i.e., 1.5 s) faster on difficulty load 4 of this task (secondary outcome): 95% CI: 0.55 to 0.06, p = 0.015. CT did not reduce subjective cognitive complaints. At follow-up, no group differences were found. Conclusions: This study shows no beneficial effect of eight-week computerized CT on the primary outcome (i.e., planning accuracy) and only minor improvements on secondary outcomes (i.e., processing speed) with limited clinical impact. Personalized or ecologically valid multi-modal intervention methods could be considered to achieve clinically meaningful and lasting effects.
引用
收藏
页码:80 / 87
页数:8
相关论文
共 50 条
  • [21] Blind Randomized Controlled Study of the Efficacy of Cognitive Training in Parkinson's Disease
    Prats Paris, Anna
    Guerra Saleta, Heidi
    Crespo Maraver, Maria de la Cruz
    Silvestre, Emmanuel
    Garolera Freixa, Maite
    Petit Torrellas, Cristina
    Alonso Pont, Silvia
    Fabra Nadal, Marc
    Alcaine Garcia, Sheila
    Perea Bartolome, Maria Victoria
    Ladera Fernandez, Valentina
    Bayes Rusinol, Angels
    MOVEMENT DISORDERS, 2011, 26 (07) : 1251 - 1258
  • [22] Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
    Masahiro Nomoto
    Yoshikuni Mizuno
    Tomoyoshi Kondo
    Kazuko Hasegawa
    Miho Murata
    Masahiro Takeuchi
    Junji Ikeda
    Takayuki Tomida
    Nobutaka Hattori
    Journal of Neurology, 2014, 261 : 1887 - 1893
  • [23] Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Nomoto, Masahiro
    Mizuno, Yoshikuni
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    JOURNAL OF NEUROLOGY, 2014, 261 (10) : 1887 - 1893
  • [24] A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease
    Payne, Thomas
    Appleby, Matthew
    Buckley, Ellen
    van Gelder, Linda M. A.
    Mullish, Benjamin H. H.
    Sassani, Matilde
    Dunning, Mark J. J.
    Hernandez, Dena
    Scholz, Sonja W. W.
    McNeill, Alisdair
    Libri, Vincenzo
    Moll, Sarah
    Marchesi, Julian R. R.
    Taylor, Rosie
    Su, Li
    Mazza, Claudia
    Jenkins, Thomas M. M.
    Foltynie, Thomas
    Bandmann, Oliver
    MOVEMENT DISORDERS, 2023, 38 (08) : 1493 - 1502
  • [25] A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease
    Damier, Philippe
    Degos, Bertrand
    Castelonovo, Giovanni
    Anheim, Mathieu
    Benatru, Isabelle
    Carriere, Nicolas
    Colin, Olivier
    Defebvre, Luc
    Deverdal, Marie
    Eusebio, Alexandre
    Ferrier, Vanessa
    Giordana, Caroline
    Houeto, Jean-Luc
    Le Dily, Severine
    Mongin, Marie
    Thiriez, Claire
    Tranchant, Christine
    Ravel, Denis
    Corvol, Jean-Christophe
    Rascol, Olivier
    Ben Ari, Yehezkel
    MOVEMENT DISORDERS, 2024, 39 (03) : 618 - 622
  • [26] Randomized, Double-Blind, Multicenter Trial of Hydrogen Water for Parkinson's Disease
    Yoritaka, Asako
    Ohtsuka, Chigumi
    Maeda, Tetsuya
    Hirayama, Masaaki
    Abe, Takashi
    Watanabe, Hirohisa
    Saiki, Hidemoto
    Oyama, Genko
    Fukae, Jiro
    Shimo, Yasushi
    Hatano, Taku
    Kawajiri, Sumihiro
    Okuma, Yasuyuki
    Machida, Yutaka
    Miwa, Hideto
    Suzuki, Chikako
    Kazama, Asuka
    Tomiyama, Masahiko
    Kihara, Takeshi
    Hirasawa, Motoyuki
    Shimura, Hideki
    Oda, Eisei
    Ito, Mikako
    Ohno, Kinji
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2018, 33 (09) : 1505 - 1507
  • [27] Facial expression in Parkinson's disease: A double-blind, randomized rehabilitation trial
    Ricciardi, L.
    Ricciardi, D.
    Morabito, B.
    Bologna, M.
    Morgante, F.
    Pomponi, M.
    Bernabei, R.
    Bentivoglio, A. R.
    Fasano, A.
    MOVEMENT DISORDERS, 2013, 28 : S142 - S143
  • [28] A Randomized, Double-Blind Trial of Transcranial Electrostimulation in Early Parkinson's Disease
    Shill, Holly A.
    Obradov, Sanja
    Katsnelson, Yakov
    Pizinger, Ray
    MOVEMENT DISORDERS, 2011, 26 (08) : 1477 - 1480
  • [29] The effect of an eight-week mindfulness training intervention on emotion related brain activation in people with Parkinson's disease
    Pickut, B. A.
    Van Hecke, W.
    Cras, P.
    Kerckhofs, E.
    Vanneste, S.
    Crosiers, D.
    Marien, P.
    Parizel, P. M.
    MOVEMENT DISORDERS, 2016, 31 : S419 - S419
  • [30] Efficacy of double-task training on gait performance in Parkinson's disease: A randomized, controlled, double-blind study
    Jabre, M. G.
    Elias, N.
    Karam, R.
    Haddad, I.
    Habib, K.
    Bejjani, B. P.
    MOVEMENT DISORDERS, 2012, 27 : S305 - S305